CLINICAL_TRIALS
trial_result
· 2010-02-03
Clinical Trial Update: Reduced Intensity AlloTransplant For Osteopetrosis [Phase 2]
Summary
Phase 2 trial update on reduced-intensity allogeneic transplantation for osteopetrosis has been terminated with posted results in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Osteopetrosis | Phase 2 | Status: TERMINATED | Results posted: 2010-02-03